Stockreport

CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering [Yahoo! Finance]

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of its "reasonable best ef [Read more]